HELIX BIOPHARMA (Germany) Performance
| HBP Stock | EUR 1.15 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and HELIX BIOPHARMA are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days HELIX BIOPHARMA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, HELIX BIOPHARMA is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 3.6 M | |
| Free Cash Flow | -6.5 M |
HELIX |
HELIX BIOPHARMA Relative Risk vs. Return Landscape
If you would invest 115.00 in HELIX BIOPHARMA on August 29, 2024 and sell it today you would earn a total of 0.00 from holding HELIX BIOPHARMA or generate 0.0% return on investment over 90 days. HELIX BIOPHARMA is producing return of less than zero assuming 0.0% volatility of returns over the 90 days investment horizon. Simply put, 0% of all stocks have less volatile historical return distribution than HELIX BIOPHARMA, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
HELIX BIOPHARMA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for HELIX BIOPHARMA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HELIX BIOPHARMA, and traders can use it to determine the average amount a HELIX BIOPHARMA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HBP |
Based on monthly moving average HELIX BIOPHARMA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HELIX BIOPHARMA by adding HELIX BIOPHARMA to a well-diversified portfolio.
HELIX BIOPHARMA Fundamentals Growth
HELIX Stock prices reflect investors' perceptions of the future prospects and financial health of HELIX BIOPHARMA, and HELIX BIOPHARMA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HELIX Stock performance.
| Current Valuation | 29.03 M | |||
| Price To Book | 50.71 X | |||
| EBITDA | (6.53 M) | |||
| Cash Flow From Operations | (6.51 M) | |||
| Total Asset | 3.73 M | |||
About HELIX BIOPHARMA Performance
Assessing HELIX BIOPHARMA's fundamental ratios provides investors with valuable insights into HELIX BIOPHARMA's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the HELIX BIOPHARMA is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about HELIX BIOPHARMA performance evaluation
Checking the ongoing alerts about HELIX BIOPHARMA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HELIX BIOPHARMA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| HELIX BIOPHARMA generated a negative expected return over the last 90 days | |
| HELIX BIOPHARMA may become a speculative penny stock | |
| HELIX BIOPHARMA has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (6.56 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| HELIX BIOPHARMA generates negative cash flow from operations |
- Analyzing HELIX BIOPHARMA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HELIX BIOPHARMA's stock is overvalued or undervalued compared to its peers.
- Examining HELIX BIOPHARMA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HELIX BIOPHARMA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HELIX BIOPHARMA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HELIX BIOPHARMA's stock. These opinions can provide insight into HELIX BIOPHARMA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for HELIX Stock Analysis
When running HELIX BIOPHARMA's price analysis, check to measure HELIX BIOPHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HELIX BIOPHARMA is operating at the current time. Most of HELIX BIOPHARMA's value examination focuses on studying past and present price action to predict the probability of HELIX BIOPHARMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HELIX BIOPHARMA's price. Additionally, you may evaluate how the addition of HELIX BIOPHARMA to your portfolios can decrease your overall portfolio volatility.